510(k) Report

510(k) · Cleared

Cleared

ABMD Software

K213760510(k) TraditionalCleared Jul 29, 2022240-day reviewClass II21 CFR 892.1170

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

HeartLung Corporation · KGI Densitometer, Bone

Cleared on Jul 29, 2022 as substantially equivalent to K894854 (Image Enhancements, 1989) after a 240-day review. Its family tree reaches back 1 generation to 1989. 2 later devices descend from it.

Decided
Jul 29, 2022
Review
240 days
Class
Class II
Product code
KGI
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K894854 (1989). 2 later devices descend from it, 2 citing it directly.

Descendants, by generation 1 generation forward: 2 descendants K894854 · QCT Bone Mineral Density Analysis Software · Image Enhancements · 19890
  1. Root · 1 generation backK894854 QCT Bone Mineral Density Analysis SoftwareImage Enhancements · 1989
  2. This deviceK213760 ABMD SoftwareHeartLung Corporation · 2022
  3. Descendant · cites it directly · 0 of its ownK252029 AI-CVDHeartLung Corporation · 2025
  4. Descendant · cites it directly · 0 of its ownK242295 BunkerHill BMDBunkerHill Health · 2025

Most influential descendants

Showing 2 of 2 · See all
  • K252029AI-CVDHeartLung Corporation · 2025 · cites it directly0descendants
  • K242295BunkerHill BMDBunkerHill Health · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K894854QCT Bone Mineral Density Analysis SoftwareImage Enhancements1989—
0 (this device)K213760ABMD SoftwareHeartLung Corporation2022—
+1K252029AI-CVDHeartLung Corporation2025—
+1K242295BunkerHill BMDBunkerHill Health2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202520
FIG. 1 — Lineage of K213760, 1989–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KGI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KGI device

  1. #1 K252718 Lunar Astrascore 13.3 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K894854QCT Bone Mineral Density Analysis Software
Summary page 4
…92.1170 Product Code: KGI 3. Predicate Device Manufacturer: Mindways Trade Name: QCT Bone Mineral Density Analysis Software Predicate 510(k): K894854 Classification: Class II, 21 CFR 892.1170 Product Code: KGI 4. Reference Device Manufacturer: Mindways…
Image Enhancements1989—
†K140342QCT Pro Asynchronous Calibration Module, CliniqctMindways Software, Inc.2014—

Also cleared against K894854: 3 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K252029AI-CVDHeartLung Corporation20250
K242295BunkerHill BMDBunkerHill Health20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K252029 (HeartLung Corporation, 2025) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K894854.

How does its category compare?

All KGI devices

KGI Densitometer, Bone: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · KGI

3in 2025

2007: 22008: 52009: 12011: 22012: 52013: 12014: 22016: 22018: 12019: 12022: 22023: 12025: 32026 (partial year): 2
2007high 5 (2008) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KGI

156in 2025

2008: 173 days median2012: 142 days median2025: 156 days median
2007high 173 (2008) · low 142 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KGI

1in 2016

2008: 62009: 92011: 12016: 1
2007high 9 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KGI

8in 2025

2008: 22009: 32011: 52012: 12013: 12014: 22016: 12017: 162018: 62020: 22021: 12022: 12023: 22024: 22025: 8
2007high 16 (2017) · low 0 (2007)2025

MAUDE reports naming product code KGI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
2008517362
20091—93
20100—00
20112—15
2012514201
20131—01
20142—02
20150—00
20162—11
20170—016
20181—06
20191—00
20200—02
20210—01
20222—01
20231—02
20240—02
2025315608
20262—0—

What is it indicated for?

The Automated Bone Mineral Density Software Module (ABMD) is a post-processing Al-powered software intended to measure bone mineral density (BMD) from existing CT scans by averaging Hounsfield units in the trabecular region of vertebral bones. ABMD is not intended to replace DXA or any other tests dedicated to BMD measurement. It is solely designed for measuring BMD in existing CT scans or CT scans ordered for reasons other than BMD measurement. In…

Read the full statement (123 words)

The Automated Bone Mineral Density Software Module (ABMD) is a post-processing Al-powered software intended to measure bone mineral density (BMD) from existing CT scans by averaging Hounsfield units in the trabecular region of vertebral bones. ABMD is not intended to replace DXA or any other tests dedicated to BMD measurement. It is solely designed for measuring BMD in existing CT scans or CT scans ordered for reasons other than BMD measurement. In summary, ABMD is an opportunistic Al-powered tool that enables: (1) retrospective assessment of bone density from CT scans acquired for other purposes, (2) assessment of bone density in conjunction with another medically appropriate procedure involving CT scans, and (3) assessment of bone density without a phantom as an independent measurement procedure.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K213760: ABMD Software.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K213760

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026